FDA 블랙박스 경고: ESCITALOPRAM

블랙박스 경고

Escitalopram Oxalate (ESCITALOPRAM) — Legacy Pharmaceutical Packaging, LLC

WARNING: SUICIDAL THOUGHTS AND BEHAVIORS WARNING: SUICIDAL THOUGHTS AND BEHAVIORS See full prescribing information for complete boxed warning. Increased risk of suicidal thoughts and behavior in pediatric and young adult patients taking antidepressants. Closely monitor all antidepressant- treated patients for clinical worsening and emergence of suicidal thoughts and behaviors (5.1). Escitalopram is not approved for use in pediatric patients less than 7 years of age (8.4). Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors [see Warnings and Precautions (5.1)]. escitalopram is not approved for use in pediatric patients less than 7 years of age [see Use in Specific Populations (8.4)].

약물 상호작용

7 DRUG INTERACTIONS Table 6 presents clinically important drug interactions with escitalopram. TABLE 6 Clinically Important Drug Interactions with escitalopram Concomitant use with SSRIs, SNRIs or Tryptophan is not recommended ( 7 ). Use caution when concomitant use with drugs that affect Hemostasis (NSAIDs, Aspirin, Warfarin) ( 7 ). 7 DRUG INTERACTIONS

주의사항

이 정보는 FDA 공공 데이터를 기반으로 하며, 의사/약사의 전문적 판단을 대체하지 않습니다.